Schedule 13G ownership disclosure
NEKTAR THERAPEUTICS
Security class unavailable · CUSIP: 640268108
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 31,629,134
- Percent of class
- 18.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-20-000073
- Form type
- SC 13G
- Filer
- Invesco Ltd.
- CIK
- CIK 914208
- Filed
- Feb 07, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership